Eagle Pharmaceuticals, Inc. Business Operations Contracts & Agreements
13 Contracts & Agreements
- Collaboration Agreements (1 contract)
- Cooperation Agreements (1)
- Development Agreements (3)
- Indemnification Agreements (1)
- Settlement Agreements (4)
- Supply Agreements (3)
- Settlement Agreement, by and between the Registrant, Teva Pharmaceuticals International GmbH, Cephalon, LLC, Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc., dated... (Filed With SEC on April 10, 2023)
- Amendment to Development and Licensing Agreement, by and between the Company and Robert One, LLC, dated December 9, 2022 (Filed With SEC on December 14, 2022)
- Settlement and License Agreement, by and between Teva Pharmaceuticals International GmbH (Filed With SEC on November 9, 2022)
- Co-operation Agreement, dated March 27, 2022, by and between Eagle Pharmaceuticals, Inc. and Acacia Pharma Group plc (Filed With SEC on March 28, 2022)
- Settlement Agreement, by and between the Registrant and Eli Lilly and Company, dated December 13, 2019 (Filed With SEC on March 2, 2020)
- Product Collaboration and License Agreement, by and between the Registrant and SymBio Pharmaceuticals Limited, effective as of September 19, 2017 (Filed With SEC on November 8, 2017)
- AMENDMENT NO. 2 TO DEVELOPMENT AND LICENSING AGREEMENT (Filed With SEC on August 11, 2015)
- AMENDMENT NO. 4 TO DEVELOPMENT AND LICENSING AGREEMENT (Filed With SEC on August 11, 2015)
- SETTLEMENT AND LICENSE AGREEMENT (Filed With SEC on May 15, 2015)
- EAGLE PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on December 20, 2013)
- SUPPLY AGREEMENT (Filed With SEC on December 20, 2013)
- DATED 14 DECEMBER 2012 AGREEMENT FOR THE SUPPLY OF ARGATROBAN AND TOPOTECAN between CIPLA LIMTED and EAGLE PHARMACEUTICALS, INC. (Filed With SEC on December 20, 2013)
- SUPPLY AND DISTRIBUTION AGREEMENT (Filed With SEC on December 20, 2013)
